Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:budesonide
|
| gptkbp:approvedBy |
1981
|
| gptkbp:ATCCode |
R03BA02
|
| gptkbp:bioavailability |
6-13% (inhaled)
|
| gptkbp:contraindication |
hypersensitivity to budesonide
|
| gptkbp:drugClass |
gptkb:Corticosteroid
|
| gptkbp:eliminationHalfLife |
2-3 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:form |
inhaler
inhalation suspension |
| https://www.w3.org/2000/01/rdf-schema#label |
Pulmicort
|
| gptkbp:legalStatus |
Rx-only (US)
POM (UK) |
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
reduces inflammation in airways
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
cough
oral thrush hoarseness |
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:budesonide
gptkb:AstraZeneca_US |
| gptkbp:bfsLayer |
6
|